Emerging biomarkers in urothelial carcinoma: Challenges and opportunities
Advanced urothelial carcinoma (UC) is a very important cause of cancer-related morbidity and mortality with, until recently, only a few available therapeutic options. The treatment landscape has dramatically changed in recent years with the introduction of immune checkpoint inhibitors and the develo...
Furkejuvvon:
| Váldodahkkit: | , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Elsevier
2020-01-01
|
| Ráidu: | Cancer Treatment and Research Communications |
| Fáttát: | |
| Liŋkkat: | http://www.sciencedirect.com/science/article/pii/S2468294220300162 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|